Christopher Hite Insider Trades & Stock Holdings

EVP & Chairman, Partnering · Royalty Pharma plc · Latest filing Jun 23, 2026

Christopher Hite, EVP & Chairman, Partnering at Royalty Pharma plc has 1 Form 4 trade on file since Jun 23, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($8.16M), net -$8.16M. Latest filing: disposed of 150K shares of $RPRX on Jun 23, 2026 at $54.39.

Trades on file

1

Open-market bought

$0

Open-market sold

$8.16M

Net open-market

-$8.16M

Latest filing

Jun 23, 2026

All insider trades by Christopher Hite

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 23, 2026	$RPRX	Sell (Open-market sale) 10b5-1	150K	$54.39	$8.16M			+1.3%	+6.6%		EVP & Chairman, Partnering		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Christopher Hite traded

• $RPRX

Frequently asked questions

Has Christopher Hite been buying or selling stock?

Christopher Hite has 0 open-market purchases and 1 open-market sale on file, net -$8.16M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Christopher Hite's latest insider trade?

disposed of 150K shares of $RPRX on Jun 23, 2026 at $54.39.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.